Founders Financial Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,534
Closed -$1.36M 402
2023
Q4
$1.36M Sell
16,534
-12
-0.1% -$915 0.15% 122
2023
Q3
$1.3M Sell
16,546
-195
-1% -$16.3K 0.17% 111
2023
Q2
$1.47M Buy
16,741
+144
+0.9% +$12.4K 0.19% 100
2023
Q1
$1.34M Buy
16,597
+814
+5% +$66.3K 0.19% 107
2022
Q4
$1.23M Buy
15,783
+4,393
+39% +$356K 0.19% 115
2022
Q3
$920K Buy
11,390
+209
+2% +$18.8K 0.16% 126
2022
Q2
$1M Buy
11,181
+69
+0.6% +$6.99K 0.2% 97
2022
Q1
$1.23M Buy
11,112
+89
+0.8% +$9.4K 0.22% 94
2021
Q4
$1.14M Buy
11,023
+551
+5% +$63.8K 0.21% 96
2021
Q3
$1.31M Buy
10,472
+637
+6% +$82.4K 0.26% 76
2021
Q2
$1.22M Buy
9,835
+380
+4% +$47.7K 0.24% 90
2021
Q1
$1.12M Buy
9,455
+245
+3% +$28.7K 0.26% 79
2020
Q4
$1.08M Sell
9,210
-591
-6% -$65.1K 0.26% 70
2020
Q3
$1.02M Buy
+9,801
New +$984K 0.32% 51
2020
Q2
Sell
-10,577
Closed -$954K 184
2020
Q1
$954K Sell
10,577
-319
-3% -$33.9K 0.35% 40
2019
Q4
$1.24M Buy
10,896
+2
+0% +$219 0.42% 47
2019
Q3
$1.18M Buy
10,894
+458
+4% +$47.8K 0.38% 53
2019
Q2
$1.02M Buy
+10,436
New +$953K 0.33% 51

Other funds holding MDT